Telangana, India

Srinivasa Rao Gella

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hetero Labs Limited. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Srinivasa Rao Gella. Retrieved from https://idiyas.com/inventor/srinivasa-rao-gella

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Srinivasa Rao Gella in Pharmaceutical Compositions

Introduction

Srinivasa Rao Gella is a notable inventor based in Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable tablet compositions. His work focuses on enhancing the efficacy and stability of medications.

Latest Patents

One of his key patents is for a stable bilayer tablet composition. This invention comprises empagliflozin, linagliptin, and pharmaceutically acceptable excipients. The formulation demonstrates no incompatibilities and exhibits good stability along with a superior dissolution profile. This innovation is crucial for improving the delivery and effectiveness of these pharmaceutical compounds.

Career Highlights

Srinivasa Rao Gella is associated with Hetero Labs Limited, a prominent pharmaceutical company. His role in the company has allowed him to contribute to various innovative projects aimed at advancing drug formulations. His expertise in the field has positioned him as a valuable asset to his team and the industry.

Collaborations

He has collaborated with notable colleagues such as Parthasaradhi Reddy Bandi and Khadgapathi Podile. These collaborations have fostered a productive environment for innovation and development within the company.

Conclusion

Srinivasa Rao Gella's contributions to pharmaceutical innovations, particularly through his patent for stable bilayer tablet compositions, highlight his commitment to improving medication efficacy. His work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…